期刊文献+

心脏再同步化治疗顽固性心力衰竭合并心房颤动 被引量:5

Cardiac resynchronization therapy for patients with refractory congestive heart failure and atrial fibrillation
下载PDF
导出
摘要 目的总结心脏再同步化治疗(CRT)合并心房颤动(房颤)的心力衰竭(心衰)的疗效,分析这类患者CRT反应的可能原因。方法 2003年3月至2007年3月接受CRT合并房颤的难治性心衰患者5例,4例为扩张型心肌病,1例为缺血性心肌病,NYHA心功能Ⅲ~Ⅳ级。4例经冠状窦途径成功置入左室电极,1例冠状窦途径失败后行右室双部位起搏(流出道间隔部和心尖部)。结果术后平均随访(12±13)个月,所有患者术后临床症状均有不同程度的改善,NYHA分级提高0+~2级;生活质量和活动耐力均有改善。平均双室起搏比例(90±9)%,其中第2、4、5例术后频发室性早搏,平均双室起搏比例偏低(77%~83%)。第2例加用胺碘酮后比例由83%升至95%,NYHA分级提高2级。5例患者先后于术后1~33个月死亡,直接死亡原因为室性心律失常者2例,心衰恶化者3例。结论 CRT同样可以使合并持续性房颤的难治性心衰患者受益,可以提高生活质量、活动耐力。保证完全的双室起搏是合并房颤的心衰患者对CRT反应的关键因素之一。合并房颤的难治性心衰患者可能更需要在严重心衰早期积极地选择CRT。部分合并房颤的难治性心衰患者,在行CRT同时应考虑植入除颤器。 Objective To evaluate the response and potential reasons of cardiac resynchronization therapy (CRT) in patients with refractory congestive heart failure (CHF) and atrial fibrillation (AF).Methods Five cases of CHF complicated by AF from March 2003 to March 2007 were enrolled.Among them,there were four cases of dilated cardiomyopathy and one case of ischemic myopathy,with NYHA class Ⅲ-Ⅳ.Left ventricular leads were successfully implanted via coronary sinus in 4 patients.It failed in one case,and then,the case was subjected to pacing at two sites of right ventricle,including high septum aspect of right ventricle and apex.Results The average follow-up duration was 12±13 months.At the final follow-up visit,improvements in symptoms,quality of life and exercise tolerance in all patients were observed,and NYHA class increased by 0+-2 grades.The average percentage of biventricular pacing (BiV-p) was (90±9)%.Case 2,4,and 5 suffered ventricular premature beat frequently,with lower percentage of BiV-p (77%-83%).The percentage of BiV-p in case 2 increased from 83% to 95% after administration of amiodarone.All 5 patients died within 1-33 months after implantation,among which,3 died of deterioration of heart failure and 2 of ventricular arrhythmias.Conclusion CRT is effective in treating CHF patients complicated by AF.High percentage of BiV-p is one of the key factors influencing the response of CRT in this group of patients.For CHF patients with AF,CRT may need to be considered in the earlier stage of CHF.CRT-defibrillator treatment may be more suitable in some of these patients.
出处 《中华老年多器官疾病杂志》 2010年第2期151-154,158,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 心脏再同步化治疗 心房颤动 心力衰竭 cardiac resynchronization therapy atrial fibrillation congestive heart failure
  • 相关文献

参考文献10

  • 1Maisel WH,Lewis E,Stevenson LW.Medical management of advanced heart failure[J].JAMA,2002,287(5):628-640.
  • 2Wang TJ,Larson MG,Levy D,et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence On mortality:the Framingham Heart study[J].Circulation,2003,107(23):2920-2925.
  • 3Abraham WT,Fisher WG,Smith AL,et al.Cardiac resynchronization in chronic heart failure[J].N Engl J Med,2002,346(24):1845-1853.
  • 4Cleland JG,Daubert jc,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure[J].N Engl J Med,2005,353(15):1539.
  • 5Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnoais and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112(12):e154-e235.
  • 6Etienne Y,Mansourati J,Gilard M,et al.Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation[J].Am J Cardiol,1999,83(7):1138-1140.
  • 7Molhoek SG,Bax JJ,Bleeker GB,et al.Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation[J].Am J Cardiol,2004,94(12):1506-1509.
  • 8Steinberg SJ.Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation[J].J Am Coll Cardiol,2006,48(4):744-746.
  • 9Gasparini M,Auricchil A,Regoli F,et al.Four-year efficacy Of cardiac resynchronization therapy on exercise tolerance and disease progression:the importance of performing atrioventricular junction ablation in patients with atrial fibrillation[J].J Am Coll Cardiol,2006,48(4):734-743.
  • 10Bristow MR,Saxon LA,Boehmer J,et al.Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure[J].N Engl J Med,2004,350(21):2140-2150.

同被引文献40

  • 1韩雅玲,臧红云,王冬梅,荆全民,王守力,王祖禄.冠状动脉介入治疗联合心脏再同步化治疗缺血性心肌病顽固性心力衰竭[J].中华心血管病杂志,2005,33(1):17-21. 被引量:30
  • 2郭继鸿.深入认识心脏再同步化治疗心力衰竭的机制[J].中国心脏起搏与心电生理杂志,2006,20(4):283-284. 被引量:62
  • 3Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 2008,117(21 ) : e350-408.
  • 4Vardas PE, Auficchio A, Blanc J J, et al. European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association. Rev Esp Cardiol, 2007,60(12) : 1272.
  • 5Wikstrom G, Blomstrb'm-Lundqvist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchrenization therapy in the CARE-HF trial. Eur Heart J,2009,30(7):782-788.
  • 6Dickstein K, Vardas PE, Aufiechio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J, 2010,31 (21):2677- 2687.
  • 7Stevenson WG, Hemandez AF, Carson PE,et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail, 2012,18(2):94-106.
  • 8Bleeker GB, Schalij M J, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients withend-stage heart failure. J Cardiovasc Electrophysiol, 2004,15 (5) : 544-549.
  • 9Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart, 2003,89( 1 ) : 54-60.
  • 10Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coil Cardiol, 2004,44( 1 ) : 1-9.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部